eXoZymes (EXOZ) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

—

Revenue (quarter)

—

Revenue growth (year over year)

—

Gross profit (trailing twelve months)

—

Gross margin

—

Net income (trailing twelve months)

—

Net income (quarter)

−$2.9M

Net income growth (year over year)

−21.96%

Net margin

—

Return on equity

−187.16%

EPS (trailing twelve months)

−$1.20

Book value per share

$0.39

P/E (trailing twelve months)

—

Price to book

11.48

Debt to assets

54.22%

Payout ratio

—

Dividend yield

—

Company profile

EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods. The company believes its platform will enable scalable production of chemical molecules found in nature in a process that is alternative to and more environmentally friendly and sustainable than the typical methods used today, such as chemical synthesis, natural extraction, and synthetic biology.

• How do I buy stock in eXoZymes (EXOZ)?

  EXOZ trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.